SABS
SABS
NASDAQ · Biotechnology

Sab Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$3.90
+0.00 (+0.00%)
As of Jun 30, 10:25 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +705.4% upside
Low Target $26.29
Average Target $31.41
High Target $48.84
Current Price $3.90
Current
$3.90
Target
$31.41
$26.29 $31.41 avg $48.84
Scenario Analysis
Bear Case
$26.29
574.1%
Low target
Base Case
$31.41
+705.4%
Avg target
Bull Case
$48.84
+1,152.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.60
-40.9% from high
52-Week Low
$1.67
+133.5% from low
Target vs 52W High
$31.41
+375.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%